As an externally managed BDC, CGBD generates shareholder returns primarily through interest income on secured loans to middle-market companies, then pays most of those earnings out as dividends. This makes the relationship between net investment income and the declared dividend the single most important number for investors to track. Over the past year, CGBD has navigated a shifting rate environment, adjusted its base dividend, and leaned on joint ventures to support returns. This quarter's results matter because they show whether core income still covers the payout and whether portfolio credit quality and NAV remain stable at a time when private credit spreads and loan origination activity are under close scrutiny. I also checked this using Tickeron’s AI Screener to see how CGBD compares to others in the industry.
For the third quarter ended September 30, 2026, Carlyle Secured Lending reported net investment income of $0.36 per share, with adjusted net investment income also at $0.36 per share. Net investment income in dollar terms came to roughly $24.98 million, a decline of about 7% from the prior-year period, while total investment income was $63.2 million.
The company's NAV per share rose modestly to $15.65 from $15.61 at the end of the prior quarter, an increase of 0.3%. Total investments held at fair value stood at approximately $2.3 billion as of September 30, 2026.
On October 28, 2026, the board declared a fourth-quarter dividend of $0.35 per share, payable on January 19, 2027, to common stockholders of record on December 31, 2026. With NII of $0.36 per share, the quarter's earnings modestly exceeded the $0.35 dividend, maintaining coverage at a time when management has emphasized preserving a stable payout supported by spillover income. From what I see, these figures line up with what I reviewed in Tickeron’s AI Daily Buy/Sell Signals for context on recent performance.
Investor focus around this report centered on dividend sustainability and portfolio stability rather than headline growth. Because BDC shares are often judged against their NAV and dividend yield, the slight quarter-over-quarter uptick in NAV and the fact that NII of $0.36 per share covered the $0.35 payout were viewed as reassuring signals. CGBD shares have continued to trade below book value, a condition management has previously addressed through share repurchases, which can be modestly accretive to NAV per share when executed at a discount. The muted year-over-year decline in net investment income reflects a softer origination environment, but the quarter's steady income coverage and stable NAV suggest the market is weighing credit resilience against slower portfolio growth.
Looking ahead, investors will be watching whether CGBD can sustain dividend coverage as interest-rate expectations continue to shift. Management has previously indicated that earnings may trough in the near term before recovering, with joint venture ramp-ups and a stronger origination pipeline expected to support income over the following quarters.
Credit quality remains a central theme. The company has emphasized low non-accruals and a conservative, senior-secured portfolio, but any increase in problem loans or markdowns could pressure NAV and, in turn, sentiment. The pace of new loan originations and the spreads on those loans will also matter, since tighter spreads can weigh on future investment income.
Finally, watch capital allocation decisions. Continued share repurchases below NAV, the growth of the company's fee-free joint ventures, and any changes to the base dividend or supplemental dividend policy will signal management's confidence in the earnings trajectory. As always with BDCs, the interplay between NII generation, credit performance, and the dividend will define the stock's outlook. I'm watching this closely as rate expectations evolve.
In my view, tools like Tickeron’s AI Trend Prediction Engine have become a useful part of my routine when evaluating income-focused names such as CGBD. It helps surface patterns in historical performance and forward signals without replacing core fundamental work. I typically run a quick scan alongside earnings data to get a broader sense of how the name stacks up in the current environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for CGBD moved above the 200-day moving average on October 01, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on CGBD as a result. In 61 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for CGBD just turned positive on October 27, 2026. Looking at past instances where CGBD's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.
CGBD moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where CGBD advanced for three days, in 175 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for CGBD crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 25%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
CGBD broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CGBD entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. CGBD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.703) is normal, around the industry mean (2.440). P/E Ratio (21.647) is within average values for comparable stocks, (-3.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.127) settles around the average of (0.267) among similar stocks. P/S Ratio (16.722) is also within normal values, averaging (15.694).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a private equity fund
Industry InvestmentManagers